ING Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.8M Sell
172,474
-242,417
-58% -$56.5M 0.21% 91
2026
Q1
$101M Buy
414,891
+852
+0.2% +$198K 0.62% 33
2025
Q4
$85.7M Sell
414,039
-545,189
-57% -$108M 0.52% 37
2025
Q3
$178M Buy
959,228
+266,299
+38% +$45.6M 0.96% 20
2025
Q2
$106M Sell
692,929
-442,195
-39% -$68M 0.64% 27
2025
Q1
$188M Buy
1,135,124
+610,314
+116% +$95.5M 1.31% 18
2024
Q4
$75.9M Buy
524,810
+193,689
+58% +$30M 0.51% 40
2024
Q3
$53.7M Sell
331,121
-170,957
-34% -$27.2M 0.31% 56
2024
Q2
$73.4M Sell
502,078
-292,869
-37% -$43.6M 0.44% 45
2024
Q1
$126M Buy
794,947
+315,579
+66% +$50.2M 0.86% 20
2023
Q4
$75.1M Buy
479,368
+14,746
+3% +$2.26M 0.6% 29
2023
Q3
$72.4M Sell
464,622
-614,324
-57% -$101M 0.64% 27
2023
Q2
$179M Buy
1,078,946
+35,018
+3% +$5.65M 1.35% 10
2023
Q1
$162M Sell
1,043,928
-62,247
-6% -$10.1M 1.57% 11
2022
Q4
$195M Buy
1,106,175
+688,896
+165% +$119M 1.96% 9
2022
Q3
$68.2M Sell
417,279
-61,187
-13% -$10.4M 1.14% 20
2022
Q2
$84.9M Sell
478,466
-80,006
-14% -$14.3M 0.98% 17
2022
Q1
$99M Buy
558,472
+103,872
+23% +$17.7M 1% 13
2021
Q4
$77.8M Buy
454,600
+193,039
+74% +$31.6M 0.7% 25
2021
Q3
$42.2M Buy
261,561
+16,282
+7% +$2.78M 0.54% 33
2021
Q2
$40.4M Buy
245,279
+38,672
+19% +$6.4M 0.64% 28
2021
Q1
$34M Sell
206,607
-3,470
-2% -$561K 0.7% 25
2020
Q4
$33.1M Sell
210,077
-76,385
-27% -$11.3M 0.74% 18
2020
Q3
$42.6M Buy
286,462
+228,513
+394% +$33.8M 1.76% 12
2020
Q2
$8.15M Sell
57,949
-425,094
-88% -$61.9M 0.35% 36
2020
Q1
$63.3M Sell
483,043
-12,933
-3% -$1.83M 2.71% 9
2019
Q4
$72.3M Sell
495,976
-12,131
-2% -$1.65M 2.2% 7
2019
Q3
$65.7M Sell
508,107
-258,806
-34% -$34.1M 1.67% 10
2019
Q2
$107M Sell
766,913
-352,840
-32% -$48.8M 1.86% 11
2019
Q1
$157M Buy
1,119,753
+509,628
+84% +$68.3M 3.39% 7
2018
Q4
$78.7M Buy
610,125
+13,795
+2% +$1.92M 1.71% 9
2018
Q3
$82.4M Buy
596,330
+46,369
+8% +$6.16M 1.42% 15
2018
Q2
$66.7M Sell
549,961
-303,352
-36% -$37.8M 1.28% 15
2018
Q1
$109M Buy
853,313
+515,503
+153% +$69.7M 1.98% 9
2017
Q4
$47.2M Sell
337,810
-338,578
-50% -$47.2M 0.79% 25
2017
Q3
$87.9M Buy
676,388
+71,614
+12% +$9.49M 1.69% 10
2017
Q2
$80M Buy
604,774
+197,944
+49% +$25.3M 1.53% 10
2017
Q1
$50.7M Buy
406,830
+16,755
+4% +$2M 0.92% 23
2016
Q4
$45M Buy
390,075
+82,363
+27% +$9.51M 0.85% 18
2016
Q3
$36.1M Sell
307,712
-733,596
-70% -$89M 0.44% 38
2016
Q2
$126M Buy
1,041,308
+982,709
+1,677% +$112M 1.7% 16
2016
Q1
$6.34M Sell
58,599
-1,935,829
-97% -$200M 0.08% 147
2015
Q4
$205M Buy
1,994,428
+741,354
+59% +$74.6M 1.23% 11
2015
Q3
$117M Sell
1,253,074
-184,728
-13% -$17.9M 0.81% 20
2015
Q2
$140M Sell
1,437,802
-759,116
-35% -$76M 0.76% 26
2015
Q1
$221M Sell
2,196,918
-496,142
-18% -$50.5M 1.11% 14
2014
Q4
$282M Buy
2,693,060
+528,919
+24% +$55.7M 1.33% 11
2014
Q3
$231M Sell
2,164,141
-19,037
-0.9% -$1.97M 1.34% 15
2014
Q2
$228M Sell
2,183,178
-1,702,561
-44% -$172M 1.15% 17
2014
Q1
$382M Buy
3,885,739
+564,006
+17% +$52.3M 2.02% 7
2013
Q4
$304M Buy
3,321,733
+745,840
+29% +$68.7M 1.53% 10
2013
Q3
$223M Buy
2,575,893
+1,301,293
+102% +$117M 1.12% 15
2013
Q2
$110M Buy
+1,274,600
New +$108M 0.58% 45

Other funds holding JNJ

ING Group's JNJ Position: Q2 2026 in Review

ING Group reduced its Johnson & Johnson (JNJ) stake by 58% in Q2 2026, selling an estimated $56.5M and leaving 172,474 shares worth $43.8M. The position accounts for 0.21% of the portfolio, ranked #91.

ING Group first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $382M in Q1 2014. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • ING Group held 172,474 shares of Johnson & Johnson worth $43.8M as of Q2 2026.
  • ING Group sold 242,417 Johnson & Johnson shares in Q2 2026, an estimated $56.5M.
  • Johnson & Johnson made up 0.21% of ING Group's portfolio in Q2 2026, its #91 holding.
  • ING Group first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • ING Group's Johnson & Johnson position peaked at $382M in Q1 2014.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.